Advanced signet-ring cell carcinoma of the stomach: Clinicopathological characteristics of patients and efficacy of the modified docetaxel, cisplatin, and fluorouracil regimen
Conclusions: mDCF is an effective regimen in patients with SRCC of the stomach who have ECOG performance score of 0–1 when the PFS, OS, and tumor response rate are considered. Further prospective studies including more patients should be conducted on this subject.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Yakup Bozkaya G & #246;kmen Umut Erdem Nuriye Yildirim & #214;zdemir Cemil Hocazade Ozan Yazici Nebi Serkan Demirci Nurullah Zengin Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Docetaxel | Gastric (Stomach) Cancer | Hematology | Hepatocellular Carcinoma | Liver | Liver Cancer | Statistics | Study | Taxotere | Thrombocytopenia | Toxicology | Urology & Nephrology